[1]
Tuladhar, P. et al. 2018. Second Line Drugs Resistant Mycobacterium Tuberculosis in Multi-Drug Resistant Tuberculosis Patients. Journal of Institute of Science and Technology. 22, 2 (Apr. 2018), 168–174. DOI:https://doi.org/10.3126/jist.v22i2.19609.